Research Article
BibTex RIS Cite
Year 2013, Volume: 30 Issue: 2, 207 - 208, 31.07.2013
https://doi.org/10.5835/jecm.omu.30.02.027

Abstract

References

  • Atakli, D., Sözüer, D., Atay, T., Baybas, S., Arpaci, B., 1998. Misdiagnosis and treatment in juvenile myoclonic epilepsy. Seizure 7, 63-66. Auvin, S., 2008. Treatment of juvenile myoclonic epilepsy. CNS Neurosci. Ther. 14, 227-233.
  • Bodenstein-Sachar, H., Gandelman-Marton, R., Ben-Zeev, B., Chapman, J., Blatt, I., 2011. Outcome of LTG treatment in juvenile myoclonic epilepsy. Acta Neurol. Scand. 124, 22-27.
  • Crespel, A., Genton, P., Berramdane, M., Coubes, P., Monicard, C., Baldy-Moulinier M., Gelisse, P., 2005. LTG associated with exacerbation or de novo myoclonus in idiopathic generalized epilepsies. Neurology. 65, 762-764.
  • Duncan, S., 2007. Teratogenesis of sodium VPA. Curr. Opin. Neurol. 20, 175-180.
  • Janszky, J., Rásonyi, G., Halász, P., Olajos, S., Perenyi, J., 2000. Disabling erratic myoclonus during lamotrigine therapy with high serum level-report of two cases. Clin. Neuropharmacol. 23, 86-89.
  • Mantoan, L., Walker, M., 2011. Treatment options in juvenile myoclonic epilepsy. Curr. Treat. Options Neurol. 13, 355-370.
  • Mehndiratta, M.M., Aggarwal, P., 2002. Clinical expression and EEG features of patients with juvenile myoclonic epilepsy (JME) from North India. Seizure. 11, 431-436.

Lamotrigine induced seizures in juvenile myoclonic epilepsy

Year 2013, Volume: 30 Issue: 2, 207 - 208, 31.07.2013
https://doi.org/10.5835/jecm.omu.30.02.027

Abstract

Juvenile myoclonic epilepsy (JME) is a common epileptic syndrome. Before the development of the new antiepileptic drugs (AEDs) after the 1990s, Valproate (VPA) was the first-line treatment in juvenile myoclonic epilepsy. However, the frequent adverse effects and the risk for teratogenicity have resulted in a search for alternative therapies especially in women. Lamotrigine (LTG), topiramate, and levetiracetam, have been used as monotherapy or adjunctive therapy for juvenile myoclonic epilepsy in small patient series. We report a case of a thirty one-years-old female suffered from severe aggravation in myoclonic and generalized tonic-clonic (GTC) seizures after decreasing the lose of VPA and initiating LTG.

References

  • Atakli, D., Sözüer, D., Atay, T., Baybas, S., Arpaci, B., 1998. Misdiagnosis and treatment in juvenile myoclonic epilepsy. Seizure 7, 63-66. Auvin, S., 2008. Treatment of juvenile myoclonic epilepsy. CNS Neurosci. Ther. 14, 227-233.
  • Bodenstein-Sachar, H., Gandelman-Marton, R., Ben-Zeev, B., Chapman, J., Blatt, I., 2011. Outcome of LTG treatment in juvenile myoclonic epilepsy. Acta Neurol. Scand. 124, 22-27.
  • Crespel, A., Genton, P., Berramdane, M., Coubes, P., Monicard, C., Baldy-Moulinier M., Gelisse, P., 2005. LTG associated with exacerbation or de novo myoclonus in idiopathic generalized epilepsies. Neurology. 65, 762-764.
  • Duncan, S., 2007. Teratogenesis of sodium VPA. Curr. Opin. Neurol. 20, 175-180.
  • Janszky, J., Rásonyi, G., Halász, P., Olajos, S., Perenyi, J., 2000. Disabling erratic myoclonus during lamotrigine therapy with high serum level-report of two cases. Clin. Neuropharmacol. 23, 86-89.
  • Mantoan, L., Walker, M., 2011. Treatment options in juvenile myoclonic epilepsy. Curr. Treat. Options Neurol. 13, 355-370.
  • Mehndiratta, M.M., Aggarwal, P., 2002. Clinical expression and EEG features of patients with juvenile myoclonic epilepsy (JME) from North India. Seizure. 11, 431-436.
There are 7 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Internal Medical Sciences
Authors

Betül Acar This is me

Ersel Dağ This is me

Yakup Türkel This is me

Publication Date July 31, 2013
Submission Date April 15, 2013
Published in Issue Year 2013 Volume: 30 Issue: 2

Cite

APA Acar, B., Dağ, E., & Türkel, Y. (2013). Lamotrigine induced seizures in juvenile myoclonic epilepsy. Journal of Experimental and Clinical Medicine, 30(2), 207-208. https://doi.org/10.5835/jecm.omu.30.02.027
AMA Acar B, Dağ E, Türkel Y. Lamotrigine induced seizures in juvenile myoclonic epilepsy. J. Exp. Clin. Med. July 2013;30(2):207-208. doi:10.5835/jecm.omu.30.02.027
Chicago Acar, Betül, Ersel Dağ, and Yakup Türkel. “Lamotrigine Induced Seizures in Juvenile Myoclonic Epilepsy”. Journal of Experimental and Clinical Medicine 30, no. 2 (July 2013): 207-8. https://doi.org/10.5835/jecm.omu.30.02.027.
EndNote Acar B, Dağ E, Türkel Y (July 1, 2013) Lamotrigine induced seizures in juvenile myoclonic epilepsy. Journal of Experimental and Clinical Medicine 30 2 207–208.
IEEE B. Acar, E. Dağ, and Y. Türkel, “Lamotrigine induced seizures in juvenile myoclonic epilepsy”, J. Exp. Clin. Med., vol. 30, no. 2, pp. 207–208, 2013, doi: 10.5835/jecm.omu.30.02.027.
ISNAD Acar, Betül et al. “Lamotrigine Induced Seizures in Juvenile Myoclonic Epilepsy”. Journal of Experimental and Clinical Medicine 30/2 (July 2013), 207-208. https://doi.org/10.5835/jecm.omu.30.02.027.
JAMA Acar B, Dağ E, Türkel Y. Lamotrigine induced seizures in juvenile myoclonic epilepsy. J. Exp. Clin. Med. 2013;30:207–208.
MLA Acar, Betül et al. “Lamotrigine Induced Seizures in Juvenile Myoclonic Epilepsy”. Journal of Experimental and Clinical Medicine, vol. 30, no. 2, 2013, pp. 207-8, doi:10.5835/jecm.omu.30.02.027.
Vancouver Acar B, Dağ E, Türkel Y. Lamotrigine induced seizures in juvenile myoclonic epilepsy. J. Exp. Clin. Med. 2013;30(2):207-8.